ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $990,854 | +77.1% | 36,509 | +100.5% | 0.00% | 0.0% |
| Q2 2023 | $559,622 | +68.4% | 18,205 | +97.4% | 0.00% | – |
| Q1 2023 | $332,304 | -8.8% | 9,223 | 0.0% | 0.00% | – |
| Q4 2022 | $364,493 | +27.9% | 9,223 | +30.3% | 0.00% | – |
| Q3 2022 | $285,000 | +46.2% | 7,078 | +52.8% | 0.00% | – |
| Q2 2022 | $195,000 | +8.3% | 4,631 | 0.0% | 0.00% | – |
| Q1 2022 | $180,000 | +68.2% | 4,631 | +71.5% | 0.00% | – |
| Q4 2021 | $107,000 | -41.8% | 2,701 | -46.8% | 0.00% | – |
| Q3 2021 | $184,000 | -12.0% | 5,081 | 0.0% | 0.00% | – |
| Q2 2021 | $209,000 | -3.2% | 5,081 | +2.8% | 0.00% | – |
| Q1 2021 | $216,000 | +116.0% | 4,944 | +147.2% | 0.00% | – |
| Q4 2020 | $100,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |